Director/PDMR Shareholding

Dechra Pharmaceuticals PLC

("the Company")

18 April 2012

Director / PDMR Shareholding

Dechra Pharmaceuticals PLC ("the Company") has been notified that on 17 April 2012 Bryan Morton, Non-Executive Director, purchased 2,804 ordinary shares in the Company at a price of 511.8514p each.

Following this acquisition Bryan Morton's beneficial interest in the Company is 2,804 shares (0.004% of current issued share capital).

For further information

Zoe Goulding, Company Secretary

Telephone number: 01782 771100